دورية أكاديمية

Effects of dietary supplementation with medicinal fungus in fasting glycemia levels of patients with colorectal cancer: a randomized, double-blind, placebo-controlled clinical study.

التفاصيل البيبلوغرافية
العنوان: Effects of dietary supplementation with medicinal fungus in fasting glycemia levels of patients with colorectal cancer: a randomized, double-blind, placebo-controlled clinical study.
المؤلفون: Fortes RC; Science and Education School Sena Aires-GO, University of Brasilia-DF, Brazil. renatacfortes@yahoo.com.br, Recôva VL, Melo AL, Novaes MR
المصدر: Nutricion hospitalaria [Nutr Hosp] 2008 Nov-Dec; Vol. 23 (6), pp. 591-8.
نوع المنشور: Journal Article; Randomized Controlled Trial
اللغة: English
بيانات الدورية: Publisher: Grupo Aran Country of Publication: Spain NLM ID: 9100365 Publication Model: Print Cited Medium: Print ISSN: 0212-1611 (Print) Linking ISSN: 02121611 NLM ISO Abbreviation: Nutr Hosp Subsets: MEDLINE
أسماء مطبوعة: Publication: 2016- : Madrid : Grupo Aran
Original Publication: Madrid : Jarpyo Editores,
مواضيع طبية MeSH: Agaricus* , Dietary Supplements*, Blood Glucose/*analysis , Colorectal Neoplasms/*blood, Double-Blind Method ; Fasting ; Female ; Humans ; Male ; Middle Aged
مستخلص: Objective: The objective of this study was to evaluate the effects of dietary supplementation with Agaricus sylvaticus medicinal fungus in fasting glycemia of post-surgery patients with colorectal cancer.
Scope: Proctology Ambulatory of Federal District Base Hospital-Brazil.
Subjects: Fifty-six colorectal cancer patients in postsurgery phase, stadiums phase I, II and II, which followed specific criteria of inclusion and exclusion.
Interventions: All patients were randomized in two groups: supplemented with Agaricus sylvaticus fungus (30 mg/kg/day) and placebo, and were followed up for six months. Subjects were divided later on according to BMI--Body Mass Index, sex and stage. Three fasting glycemia evaluations were carried out throughout the treatment.
Results: Subjects presented BMI medium = 24.65 kg/m2 (57.1% women and 42.9% men). The placebo group (average age 59.14 +/- 12.95 years) had initial glycemia levels of 94.36 +/- 15.34 mg/dL, after three months 98.12 +/- 15.54 mg/dL (p = 0.03) and in the sixth month 98.52 +/- 9.03 mg/dL (p = 0.01). The supplemented group (average age of 56.34 +/- 15.53 years) had initial glycemia levels of 95.92 +/- 11.64 mg/dL, after three months 94.88 +/- 12.24 mg/dL (p = 0.65) and, in the sixth month, a significant reduction to 92.86 +/- 6.82 mg/dL (p = 0.01).
Conclusion: The results suggest that the dietary supplementation with Agaricus sylvaticus medicinal fungus can significantly reduce fasting glycemia levels of colorectal cancer patients in post-surgery phase.
المشرفين على المادة: 0 (Blood Glucose)
تواريخ الأحداث: Date Created: 20090110 Date Completed: 20090330 Latest Revision: 20130702
رمز التحديث: 20231215
PMID: 19132268
قاعدة البيانات: MEDLINE